Nephro Care India Ltd IPO

Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients. As on date, Nephro Care is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. The operations of Nephro Care are supported by a pool of expert Doctors, experienced and well-trained paramedical professionals and a skilled management team. The entire team at Nephro Care is supported by sufficient clinical and investigative infrastructure.

Open Demat Account

50years

Nephro Care India Ltd IPO Details

Details

Total Shares OfferedOffer to PublicRetail Max (Shares)Pre Issue Promoters HoldingExchangeIssue size
45.84 LTBA14.45 L100 LNSE₹ 41.26 Cr
IPO Open DateClose DateLot SizeMin InvestmentIssue TypeListing Date
28 Jun, 2402 Jul, 241600 ₹ 1,36,000 Book Building - SME05 Jul, 24

Nephro Care India Ltd IPO Dates

  • 28 Jun 2024

    Opening date

  • 02 Jul 2024

    Closing date

  • 03 Jul 2024

    Basis of
    Allotment

  • 04 Jul 2024

    Initiation of
    Refunds

  • 04 Jul 2024

    Credit of
    Shares

  • 05 Jul 2024

    Listing date

Details

SectorType
SectorHealthcare
Sub SectorNA
Issue TypeBook Building - SME

Subscription Status

*Values are in Lakhs

Investor TypeSubscription TimesShares Offered*Shares Bid*
QIB98.06x2064000202387200
NII1787.56x6192001106856000
Retail634.13x1444800916184000
Employee0x2256000
Total486.48x45840002230038400

Subscription Status

Investor Type

QIB

NII

Retail

Employee

Total

*Values are in Lakhs

Nephro Care India Ltd Financial Status

Income Statement

Balance Sheet

Particulars (in Rs. Crores)FY23FY22FY21
Revenue from operations3.500.110.13
EBITDA4.290.220.14
PAT1.94-0.010.09
Total Assets3.041.090.52
Share Capital0.500.500.01
Total Borrowings0.240.240.19
Operating Activities (Net Cash)2.730.100.10
Investing Activities (Net Cash)2.00-1.90-0.45
Financing Activities (Net Cash)0.240.240.19
Net Cashflow2.320.610.48

Particulars (in Rs. Crores)

Revenue from operations

EBITDA

PAT

Total Assets

Share Capital

Total Borrowings

Operating Activities (Net Cash)

Investing Activities (Net Cash)

Financing Activities (Net Cash)

Net Cashflow

About Nephro Care India Ltd

Our Company was originally incorporated on July 08, 2014 as a Private Limited Company as Nephro Care India Private Limited under the provisions of the Companies Act, 2013 with the Registrar of Companies, West Bengal. Subsequently, our Company was converted into a public limited company pursuant to a resolution passed by our Shareholders at an extraordinary general meeting held on December 26, 2023 and consequently the name of our Company was changed to `Nephro Care India Limited' and a fresh certificate of incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. The corporate identification number of our Company is U85100WB2014PLC202429.

CKD is a severe public health issue in India. As per government estimates, nearly 2,20,000 patients develop end-stage renal disease (ESRD) annually in India, leading to an additional annual dialysis demand of 34 million treatment sessions. Unfortunately, in India, renal insufficiency treatment focuses more on curative nephrology rather than preventive and holistic solutions. Kidney disease is a significant public health concern in India, with high morbidity and mortality rates. The Million Death Study estimated a 50% increase in deaths due to chronic kidney disease (CKD) between 2001-2003 and 2010-2013. Several surveys have shown a high population prevalence of CKD. As many as one out of every five adults in high-prevalence areas has CKD. Similarly, acute kidney injury is common and carries a high mortality, especially because treatment is frequently delayed. However, the National Programme for Prevention & Control of Cancer, Diabetes, Cardio-vascular diseases and Stroke (NPCDCS), the flagship NCD prevention programme in India, does not cover kidney care.

Peer Comparison:

  • No Listed Industry Peers

Nephro Care India Ltd IPO Key Points

Strengths

  • We bridge the gap between day care and tertiary care services by addressing unmet needs through a blend of modern medical science and time tested yogic wisdom for overall wellbeing of the patients.
  • Our technology backbone is robust and supports consistent improvements in the quality and efficiency of our service delivery.
  • Track record of operating and financial performance and growth.
  • Professional management and experienced leadership.
  • Investment in infrastructure, processes and clinical services delivery framework, affordability resulting in a strong value proposition for stakeholders.

Risk

  • Its Promoter, Dr. Pratim Sengupta, plays a key role in the company functioning and its heavily relies on his knowledge and experience in operating its business and therefore, it is critical for the company's business that its Promoter remain associated with the company.
  • Its expansion into new business vertical, i.e. setting up a hospital, may expose the company to new challenges and more risks.
  • The company's revenues are significantly dependent on its flagship Salt Lake clinic. Further, all its clinics are located in the Kolkata. Any impact on the revenues of its flagship Salt Lake clinic or any change in the economic or political circumstances of West Bengal or particularly in or around Kolkata, could materially affect its business, financial condition and results of operations.

Strategy

  • Continue to invest in extension of our Hub-and-Spoke network.
  • Continue to attract, engage and train prominent, skilled doctors and other healthcare professionals.
  • Enhance clinical capabilities and improve operating efficiencies.
  • Extend clinical services outside the clinic and across the lifetime of the patient.
  • Leverage technology to improve patient experience and grow our digital health services.
  • We bridge the gap between day care and tertiary care services by addressing unmet needs through a blend of modern medical science and time tested yogic wisdom for overall wellbeing of the patients.
  • Our technology backbone is robust and supports consistent improvements in the quality and efficiency of our service delivery.
  • Track record of operating and financial performance and growth.
  • Professional management and experienced leadership.
  • Investment in infrastructure, processes and clinical services delivery framework, affordability resulting in a strong value proposition for stakeholders.

How To Apply for Nephro Care India Ltd Online?

Step 1:

Log in to the BlinkX stock market app and click ‘IPO’ in the Xplore section.

Step 2:

From the list of open IPOs, select the IPO you want to invest.

Step 3:

Go through the IPO details like lot size, price band, about the company, etc.

Step 4:

Click ‘Apply IPO’ to apply and enter the number of lots and bidding price along with your UPI ID.

Step 5:

Confirm your bid and accept the payment mandate sent to your UPI App for completing the IPO application.

Get your FAQs right

Nephro Care India Ltd's IPO offers shares for up to ₹ 0 L It begins on Jun 28, 2024 and ends on Jul 2, 2024.

The price of Nephro Care India Ltd IPO ranges between ₹85 to ₹90 per share.

The Nephro Care India Ltd IPO opens on Jun 28, 2024 and closes on Jul 2, 2024.

The allotment for the Nephro Care India Ltd IPO will be finalised on Jul 3, 2024. The shares will be listed on BSE and NSE on Jul 5, 2024.

The minimum lot size for Nephro Care India Ltd IPO is 1600 shares, priced between ₹85 to ₹90 per share.

The GMP (Grey Market Premium) of Nephro Care India Ltd IPO fluctuates based on market demand and sentiment.

To check the allotment status of Nephro Care India Ltd IPO, visit the registrar's website, select the IPO, enter your PAN Card number, Application Number, or DP Client ID, and click 'search.'

The Nephro Care India Ltd IPO is getting listed on the BSE and NSE. Bidding opens on Jun 28, 2024, and closes on Jul 2, 2024. The allotment is finalised on Jul 3, 2024.

To apply for the Nephro Care India Ltd IPO, download the BlinkX app, complete KYC, select the IPO, enter bid details, and submit. Verify UPI payment for shares allotment.